Pancreatic islet PEGylation as an immunological polymeric restraint

Biotechnology and Bioprocess Engineering

Volumn 15, Issue 1, 2010, Pages 76-85

  Lee, Dong Yun ^a   Byun, Youngro ^b  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Diabetes mellitus; Immunoprotection; Pancreatic islet; PEGylation; Transplantation

Indexed keywords

DIABETES MELLITUS; IMMUNE TOLERANCES; IMMUNO-ISOLATION; IMMUNOGENICITY; IMMUNOPROTECTION; PANCREATIC ISLET; PEGYLATION; SYNERGISTIC EFFECT; TYPE 1 DIABETES MELLITUS;

DRUG THERAPY;

ALGINIC ACID; BILIVERDIN; CYCLOSPORIN A; MACROGOL; POLYELECTROLYTE; POLYLYSINE;

HUMAN; IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; LOW DRUG DOSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; REVIEW;

EID: 77953583276     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12257-009-3063-7     Document Type: Review

References (75)

1. Bloomgarden, Z. T. (2004) Diabetes complications. Diabetes Care 27: 1506-1514.
2. Hill, J. (2004) Identifying and managing the complications of diabetes. Nurs. Times 100: 40-44.
3. Ricordi, C. and T. B. Strom (2004) Clinical islet transplantation: advances and immunological challenges. Nat. Rev. Immunol. 4: 259-268.
4. Shapiro, A. M. J., S. A. Nanji, and J. R. Lakey (2003) Clinical islet transplant: current and future directions towards tolerance. Immunol. Rev. 196: 219-236.
5. Shapiro, A. M. J., E. A. Ryan, and J. R. Lakey (2001) Diabetes. Islet cell transplantation. Lancet 358: 21.
6. Mathieu, C. (2001) Current limitation of islet transplantation. Transplantation proceedings 33: 1707-1708.
7. Ryan, E. A., J. R. Lakey, B. W. Paty, S. Imes, G. S. Korbutt, N. M. Kneteman, D. Bigam, R. V. Rajotte, and A. M. J. Shapiro (2002) Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51: 2148-2157.
8. Cole, D. R., M. Waterfall, M. McIntyre, and J. D. Baird (1992) Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia 35: 231-237.
9. Pukel, C., H. Baquerizo, and A. Rabinovitch (1988) Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37: 133-136.
10. Kessler, L., C. Jesser, Y. Lombard, V. Karsten, A. Belcourt, M. Pinget, and P. Poindron (1996) Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: in vivo and in vitro studies. J. Leukoc. Biol. 60: 729-736.
11. Southern, C., D. Schulster, and I. C. Green (1990) Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett. 276: 42-44.
12. Kuttler, B., H. Wanka, and H. J. Hahn (1997) Co-culture of pancreatic islets and allogeneic lymphocytes: alterations of responder and stimulator cells. Transplantation 64: 480-489.
13. Jones, T. R., J. Ha, M. A. Williams, A. B. Adams, M. M. Durham, P. A. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen (2002) The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts. J. Immunol. 168: 1123-1130.
14. Campbell, I. L., A. Iscaro, and L. C. Harrison (1988) IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141: 2325-2329.
15. Kroncke, K. D., V. Kolb-Bachofen, B. Berschick, V. Burkart, and H. Kolb (1991) Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175: 752-758.
16. Shapiro, A. M. J., J. R. Lakey, E. A. Ryan, G. S. Korbutt, E. Toth, G. L. Warnock, N. M. Kneteman, and R. V. Rajotte (2000) Islet transplantation in seven patients with type I diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343: 230-238.
17. Ryan, E. A., J. R. T. Lakey, R. V. Rajotte, G. S. Korbutt, T. Kin, S. Imes, A. Rabinovitch, J. F. Elliott, D. Bigam, N. M. Kneteman, G. L. Warnock, I. Larsen, and A. M. J. Shapiro (2001) Clinical outcomes and insulin secretion after islet transplantation with the edmonton protocol. Diabetes 50: 710-719.
18. Robertson, R. P. (2004) Islet transplantation as a treatment of diabetes - a work in progress. N. Engl. J. Med. 350: 694-705.
19. Platz, K. P., A. R. Mueller, G. Blumhardt, S. Bachmann, W. O. Bechstein, A. Kahl and P. Neuhaus (1994) Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 58: 170-178. (Pubitemid 24236210)
20. Taler, S. J., S. C. Textor, V. J. Canzanello, L. Schwartz, M. Porayko, R. H. Wiesner, and R. A. Krom (1996) Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. Transplantation 62: 1588-1592.
21. Ayres, R. C., B. Dousset, S. Wixon, J. A. Buckels, P. McMaster, and A. D. Mayer (1994) Peripheral neurotoxicity with tacrolimus. Lancet 343: 862-863.
22. Mach-Pascual, S., K. Samii, and P. Beris (1996) Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Am. J. Hematol. 52: 310-312.
23. Lanza, R. P., J. L. Hayes, and W. L. Chick (1996) Encapsulated cell technology. Nat. Biotechnol. 14: 1107-1111.
24. de Vos, P., A. F. Hamel, and K. Tatarkiewicz (2002) Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45: 159-173. (Pubitemid 34208378)
25. Lanza, R. P., W. M. Kuhtreiber, D. Ecker, J. E. Staruk, and W. L. Chick (1995) Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 59: 1377-1384.
26. Iwata, H., T. Takagi, H. Shimizu, K. Yamashita, K. Kobayashi, and T. Akutsu (1992) Agarose for bioartificial pancreas. J. Biomed. Mater. Res. 26: 967-977.
27. Teramura, Y., Y. Kaneda, and H. Iwata (2007) Isletencapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28: 4818-4825.
28. Panza, J. L., W. R. Wagner, H. L. R. Rilo, R. H. Rao, E. J. Beckman, and A. J. Russell (2002) Treatment of rat pancreatic islets with reactive PEG. Biomaterials 21: 1155-1164
29. Contreras, J. L., D. Xie, J. Mays, C. A. Smyth, C. Eckstein, F. G. Rahemtulla, C. J. Young, J. A. Thompson, G. Bilbao, D. T. Curiel, and D. E. Eckhoff (2004) A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. Surgery 136: 537-547.
30. Xie, D., C. A. Smyth, C. Eckstein, G. Bilbao, J. Mays, D. E. Eckhoff, and J. L. Contreras (2005) Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation. Biomaterials 26: 403-412.
31. Cruise, G. M., O. D. Hegre, F. V. Lamberti, S. R. Hager, R. Hill, D. S. Scharp, and J. A. Hubbell (1999) In vitro and in vivo performance of porcine islets encapsulated in interfacially photoplolymerized poly(ethylene glycol) diacrylate membrane. Cell Transplant 8: 293-306.
32. Hill, R. S., G. M. Cruise, S. R. Hager, F. V. Lamberti, X. Yu, C. L. Garufis, Y. Yu, K. E. Mundwiler, J. F. Cole, J. A. Hubbell, O. D. Hegre, and D. W. Scharp (1997) Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of massisolated porcine islets. Ann. N. Y. Acad. Sci. 831: 332-343.
33. Cruise, G. M., O. D. Hegre, D. S. Scharp, and J. A. Hubbell (1998) Asensitivity study of the key parameters in the interfacial photopolymerization of poly(ethylene glycol) diacrylate upon porcine islets. Biotechnol. Bioeng. 57: 655-665.
34. Hoofman, G., S. Herman, and E. Schacht (1995) Poly(ethylene glycol) with reactive end groups: I. Modification of proteins. J. Bioact. Compat. Pol. 10: 145-187.
35. Hershfield, M. S. (1997) Biochemistry and immunology of poly(ethylene glycol)-modified adenosine deaminase (PEG-ADA). pp 170-181. In: J. M. Harris and S. Zalipsky (eds.). Poly(ethylene glycol) chemistry and biological applications. American Chemical Society. Washington, DC, USA.
36. Scott, M. D., K. L. Murad, F. Koumpouras, M. Talbot, and J. W. Eaton (1997) Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc. Natl. Acad. Sci. USA 94: 7566-7571.
37. Murad, K. L., K. L. Mahany, C. Brugnara, F. A. Kuypers, J. W. Eaton, and M. D. Scott (1999) Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 93: 2121-2127.
38. Murad, K. L., E. J. Gosselin, J. W. Eaton, and M. D. Scott (1999) Stealth cells: prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood 94: 2135-2141.
39. Hashemi-Najafabadi, S., E. Vasheghani-Farahani, S. A. Shojaosadati, M. J. Rasaee, J. K. Armstrong, M. Moin, and Z. Pourpak (2006) A method to optimize PEGcoating of red blood cells. Bioconjug. Chem. 17: 1288-1293.
40. Nacharaju, P., F. N. Boctor, B. N. Manjula, and S. A. Acharya (2005) Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells. Transfusion 45: 374-383.
41. Lee, D. Y., K. Yang, S. Lee, S. Y. Chae, K. W. Kim, M. K. Lee, D. J. Han, and Y. Byun (2002) Optimization of monomethoxy-polyethylene glycol grafting on the pancreaticislet capsules. J. Biomed. Mater. Res. 62: 372-377.
42. Lee, D. Y., J. H. Nam, and Y. Byun (2007) Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year. Biomaterials 28: 1957-1966.
43. Lee, D. Y., S. J. Park, J. H. Nam, and Y. Byun (2006) A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: long-functioning PEGylated islets in vitro. Tissue Eng. 12: 615-623.
44. Lee, D. Y., J. H. Nam, and Y. Byun (2004). Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocyte and cytokine attacks. J. Biomater. Sci. Polymer Edn. 15: 753-766.
45. Grodsky, G. M. (1989) A new phase of insulin secretion, how will it contribute to our understanding of β-cell function. Diabetes 38: 673-678.
46. Narang, A. S. and R. I. Mahato (2006) Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev. 58: 194-243.
47. Decher, G. (1997) Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 277: 1232-1237.
48. Quinn, J. F., A. P. R. Johnston, G. K. Such, A. N. Zelikin, and F. Caruso (2007) Next generation, sequentially assembled ultrathin films: beyond electrostatics. Chem. Soc. Rev. 36: 707-718.
49. Hammond, P. T. (2004) Form and function in multilayer assembly: New applications at the nanoscale. Adv. Mater. 16: 1271-1293.
50. Elbert, D. L., C. B. Herbert, and J. A. Hubbell (1999) Thin polymer layers formed by polyelectrolyte multilayer techniques on biological surfaces. Langmuir 15: 5355-5362.
51. Thierry, B., F. M. Winnik, Y. Merhi, and M. Tabrizian (2003) Nanocoatings onto arteries via layer-by-layer deposition: toward the in vivo repair of damaged blood vessels. J. Am. Chem. Soc. 125: 7494-7495.
52. Hong, S., P. R. Leroueil, E. K. Janus, J. L. Peters, M. M. Kober, M. T. Islam, B. G. Orr, J. R. Baker, jr., and M. M. Banaszak Holl (2006) Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chem. 17: 728-734.
53. Chanana, M., A. Gliozzi, A. Diaspro, I. Chodnevskaja, S. Huewel, V. Moskalenko, K. Ulrichs, H. J. Galla, and S. Krol (2005) Interaction of polyelectrolytes and their composites with living cells. Nano Lett. 5: 2605-2612.
54. Fischer, D., Y. X. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24: 1121-1131.
55. Wilson, J. T., W. X. Cui, and E. L. Chaikof (2008) Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett. 8:1940-1948.
56. Lee, D. Y., S. J. Park, S. Lee, J. H. Nam, and Y. Byun (2007) Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication. Tissue Eng. 13: 2133-2141.
57. Krol, S., S. del Guerra, M. Grupillo, A. Diaspro, A. Gliozzi, and P. Marchetti (2006) Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett. 6: 1933-1939.
58. Miura, S., Y. Teramura, and H. Iwata (2006) Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 27: 5828-5835.
59. Jang, J. Y., D. Y. Lee, S. J. Park, and Y. Byun (2004) Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Biomaterials 25: 3663-3669.
60. Lee, R. S., M. J. Grusby, L. H. Glimcher, H. J. Winn, and H. Auchincloss (1994) Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179: 865-872.
61. Sayegh, M. H., B. Watschinger, and C. B. Carpenter (1994) Mechanisms of T cell recognition of alloantigen. The role of peptides. Transplantation 57: 1295-1302.
62. Mikos, A. G., L. V. McIntire, J. M. Anderson, and J. E. Babensee (1998) Host response to tissue engineered devices. Adv. Drug Deliv. Rev. 33: 111-139.
63. Rabinovitch, A., W. L. Suarez-Pinzon, A. M. J. Shapiro, R. V. Rajotte, and R. Power (2002) Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes 51: 638-645.
64. Shapiro, A. M. J., W. L. Suarez-Pinzon, R. Power, and A. Rabinovitch (2002) Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Diabetologia 45: 224-230.
65. Lee, D. Y., S. J. Park, J. H. Nam, and Y. Byun (2006) A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation. J. Control. Release 110: 290-295.
66. Lee, D. Y., J. H. Nam, and Y. Byun (2006) Minimization of immunosuppressive therapy for islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet. Am. J. Transplant. 6: 1820-1828.
67. Dibelius, A., H. Konigsberger, P. Walter, W. Permanetter, W. Brendel, and B. U. von Specht (1986) Prolonged reversal of diabetes in the rat by transplantation of allogeneic islets from a single donor and cyclosporine treatment. Transplantation 41: 426-431.
68. Gotoh, M., T. Maki, S. Satomi, J. Porter, and A. P. Monaco (1986) Immunological characteristics of purified pancreatic islet grafts. Transplantation 42: 387-390.
69. Pileggi, A., R. D. Molano, T. Berney, P. Cattan, C. Vizzardelli, R. Oliver, C. Fraker, C. Ricordi, R. L. Pastori, F. H. Bach, and L. Inverardi (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50: 1983-1991.
70. Ye, J. and S. G. Laychock (1998) A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1beta. Endocrinology 139: 4155-4163.
71. Tobiasch, E., L. Gunther, and F. H. Bach (2001) Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J. Investig. Med. 49: 566-571.
72. Tenhunen, R., H. S. Marver, and R. Schmid (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA 61: 748-755.
73. Lee, T. S. and L. Y. Chau (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8: 240-246.
74. Soares, M. P., Y. Lin, J. Anrather, E. Csizmadia, K. Takigami, K. Sato, S. T. Grey, R. B. Colvin, A. M. Choi, K. D. Poss, and F. H. Bach (1998) Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4: 1073-1077.
75. Sato, K., J. Balla, L. Otterbein, R. N. Smith, S. Brouard, Y. Lin, E. Csizmadia, J. Sevigny, S. C. Robson, G. Vercellotti, A. M. Choi, F. H. Bach, and M. P. Soares (2001) Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplant. J. Immunol. 166: 4185-4194.